ABSTRACT
Introduction
The loss or failure of an organ or tissue is one of the most frequent, devastating, and costly problems in health care as the availability of compatible donors are severely limited. [1] The currently used alternatives such as mechanical devices or artificial prostheses do not repair the tissue or organ function and are not intended to integrate into the host tissue. Additionally, mechanical devices or artificial prostheses may be subjected to wear upon long-term implantation, and could induce inflammatory response in the host. [2] The use of synthetic restorative materials as substitutes for dental structures is a practice nearly as old as dentistry itself. [3] To date, most of the procedures performed in dentistry are limited to the replacement of damaged tissues for biocompatible synthetic materials that may not present chemical, biological, or physical characteristics and behaviors similar to the host tissues. These discrepancies, together with the hostile environment of the oral cavity, result in relatively short-lived successful outcomes and frequent need for retreatment.
Current strategies used for treatment of lost tissues include the utilization of autogenous grafts, allografts, and synthetic materials (alloplasts). One of the major shortcomings with autografts, aswell as allografts, is the fact that humans do not have significant stores of excess tissue for transplantation. Also donor site morbidity, anatomic and structural problems, and elevated levels of resorption during healing might occur. [4] Whereas in case of allografts, there always exists the possibility of eliciting an immunologic response due to genetic differences, as well as inducing transmissible diseases. [5] On the other hand with the use of synthetic material replacements (e.g., dental implants) as part of a natural defense mechanism, the body has a tendency to encapsulate foreign materials in a thin, fibrous membrane. In case of dental implant, the fibrous capsule created by the immune response can potentially wall off the implant from its new environment and can prevent the implant from achieving true osseointegration, ultimately leading to failure. [6] The term tissue engineering was initially defined by the attendees of the first National Scientific Foundation (NSF) sponsored meeting in 1988 as "application of the principles and methods of engineering and life sciences toward fundamental understanding of structure function relationship in normal and pathological mammalian tissues and the development of biological substitutes for the repair or regeneration of tissue or organ function." [7] In 1993, Langer and Vacanti summarized the early developments in this field and defined tissue engineering as "an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain or improve tissue or organ function." [8] Strategies to engineer tissue Currently, strategies employed to engineer tissue can be categorized into three major classes: conductive, inductive, and cell transplantation approaches. These approaches all typically utilize a material component, although with different goals.
Conductive approaches utilize biomaterials in a passive manner to facilitate the growth or regenerative capacity of existing tissue. An example of this in the field of periodontics, is the use of barrier membranes in guided tissue regeneration by Nyman et al. [9] In the field of prosthetic and restorative dentistry the widespread application of this osteoconductive approach is osseointegration of dental implants by Branemark.
The second major tissue engineering strategy (induction) involves activating cells in close proximity to the defect site with specific biological signals. The origins of this mechanism was with the discovery of bone morphogenetic proteins (BMPs).Urist first showed that new bone could be formed at nonmineralizing, or ectopic, sites after implantation of powdered bone (bone demineralized and ground into fine particles). [10] Contained within the powdered bone were proteins (BMPs), which turned out to be the key elements for inducing bone formation. One limitation of inductive approaches is that the inductive factors for a particular tissue may not be known.
The third tissue engineering approach, cell transplantation, becomes very attractive in such situations. This approach involves direct transplantation ofcells grown in the laboratory. [11] Here tissue biopsy from the patient is taken to the laboratory and multiplied several million fold. Principles of cell biology must be employed in order to grow these cells and sustain their function. Engineers manufacture the biodegradable polymer matrices and the tissue growth bioreactor in which the tissue will grow. Once the cells have been expanded to an appropriate number, they are placed (seeded) onto the polymer scaffold. The tissue is then allowed further growth in the bioreactor until time of transplantation. After transplantation, the engineered tissue may continue to grow until completely developed.
The triad of tissue engineering
Tissue engineering is generally considered to consist of three key components: (i) stem/progenitor cells; (ii) a scaffold or extracellular matrix.
(iii) Signaling molecules In addition, growing tissues require an adequate vascular supply to ensure viability and an unencumbered physical space into which the growing tissue can expand.
Stem Cells
Stem cells are clonogenic cells capable of self-renewal and capable of generating differentiated progenies. These cells are responsible for normal tissue renewal as well as for healing and regeneration after injuries. [12] Stem cells may be:  Totipotent, i.e. early embryonic cells (one to three days from oocyte fertilization), which can give rise to all the embryonic tissues and placenta.  Pluripotent, i.e. embryonic cells from blastocyst (4-14 days after oocyte fertilization), which can differentiate only into embryonic tissues belonging to the inner cell mass (ectoderm, mesoderm, and endoderm).
 Multipotent, i.e. embryonic cells from the 14th day onwards, which can give rise to tissues belonging to only one embryonic germ layer (ectoderm or mesoderm or endoderm). [13] Depending on the development stage of the tissues from which the stem cells are isolated, stem cells can be broadly divided into two categories: Adult stem cells and embryonic stem cells. [14] [15] [16] Embryonic stem cells are derived from embryos that are 2 -11 days old called blastocysts. Adult stem cells are multipotent stem cells, and depending upon their origin, they can be further classified into hemopoetic stem cells and mesenchymal stem cells. Friedenstein and colleagues first identified mesenchymal stem cells in aspirates of adult bone marrow. [17] Among the adults stem cells, bone marrow-derived stem cells or mesenchymal stem cells (MSCs) are adherent, proliferating, and capable of multilineage differentiation having the capability of differentiating into multiple tissue types, including bone, cartilage, muscle, tendon, etc., and hold great potential for autologous cell based therapy. [16] In dentistry, the identification of mesenchymal stem cell-like populations has presented possibilities for the application of tissue engineering in the development of novel strategies for regenerative periodontal therapy. Seo PDLSCs also demonstrate the capacity to form collagen fibers, similar to Sharpey's fibers, connecting to the cementum like tissue, suggesting the potential to regenerate PDL attachment. [18] Scaffold / extracellular matrix Scaffolds are temporary frameworks used to provide a three dimensional microenvironment where cells can proliferate, differentiate and generate the desired tissue. [19] A suitable bioactive three dimensional scaffold for the promotion of cellular proliferation and differentiation is critical in periodontal tissue engineering. The contemporary concept of scaffolding in tissue engineering is to mimic the functions of native extracellular matrix (ECM), at least partially.
A scaffold plays many roles in tissue regeneration process: [20] • It serves as a framework to support cellular migration into the defect from surrounding tissues.
• It serves as a delivery vehicle for exogenous cells, growth factors and genes.
• It may structurally reinforce the defect to maintain the shape of the defect.
• It serves as a barrier to prevent infiltration of surrounding tissue that may impede the process of regeneration.
• Before its absorption, a scaffold can serve as a matrix for exogenous and endogenous cell adhesion and thus facilitates and regulates certain cellular processes, including mitosis, synthesis and migration.
Biomaterials used as scaffolds
In the first Consensus Conference of the European Society for Biomaterials (ESB) in 1976, a biomaterial was defined as 'a nonviable material used in a medical device, intended to interact with biological systems'; however, the ESB's current definition is a 'material intended to interface with biological systems to evaluate, treat, augment or replace any tissue, organ or function of the body'. This subtle change in definition is indicative of how the field of biomaterials has evolved. Biomaterials have moved from merely interacting with the body to influencing biological processes toward the goal of tissue regeneration. [21] Typically, three individual groups of biomaterials namely ceramics, synthetic polymers and natural polymers, are used in the fabrication of scaffolds for tissue engineering.  Ceramic scaffolds-mainly for bone regeneration applications Hydroxyapatite (HA) and tri-calcium phosphate (TCP) are the ceramic scaffolds. The interactions of osteogenic cells with ceramics are important for bone regeneration as ceramics are known to enhance osteoblast differentiation and proliferation. [22, 23] However, their clinical applications for tissue engineering has been limited because of their brittleness, difficulty of shaping for implantation, and because new bone formed in a porous HA network cannot sustain the mechanical loading needed for remodeling. [24] In addition, although HA is a primary constituent of bone and might seem ideal as a bone graft substitute, problems also exist in that it is difficult to control its degradation rate.  Synthetic polymersPolystyrene, poly-l-lactic acid (PLLA),polyglycolic acid (PGA) and poly-dllactic-co-glycolic acid (PLGA) are the synthetic polymers. They can be fabricated with a tailored architecture, and their degradation characteristics can be controlled by varying the polymer itself or the composition of the individual polymer [25] [26] [27] .They have drawbacks like the risk of rejection due to reduced bioactivity. In addition, concerns exist about the degradation process of PLLA and PGA as they degrade by hydrolysis, producing carbon dioxide and therefore lowering the local pH which can result in cell and tissue necrosis [28] .
 Natural or biologic materialsCollagen, various proteoglycans, alginatebased substrates and chitosan are the natural scaffolds. They are biologically active and typically promote excellent cell adhesion and growth. Furthermore, they are also biodegradable and so allow host cells, over time, to produce their own extracellular matrix and replace the degraded scaffold. 
Signalling molecules
Signaling molecules are proteins that may act locally or systemically to influence the growth and function of cells in various manners. [31] These molecules (cytokines) are biological mediators that regulate critical cellular activities including:
• Mitogenic (proliferative) • Chemotactic (stimulate directed migration of cells)
• Angiogenic (stimulate the formation of new blood vessels).
The two types of signaling molecules that have received the greatest attention are growth factors and morphogens that act by altering the cell phenotype i.e. by causing the differentiation of stem cells into bone forming cells -a process commonly known as osteoinduction.
Growth factors
Growth factors are naturally occurring proteins that regulate various aspects of cell growth and development. [32, 33] During wound healing, these growth factors modulate cell proliferation, differentiation migration, extracellular matrix formation and other cellular functions. In periodontal regeneration, much of the focus has been on platelet-derived growth factor and basic fibroblast growth factor-2.
Morphogens or differentiation factors: bone morphogenetic proteins
Bone morphogenetic proteins are a group of regulatory glycoproteins that are members of the transforming growth factor-beta superfamily. These molecules primarily stimulate differentiation of mesenchymal stem cells into chondroblasts and osteoblasts. In the field of periodontal regeneration, BMPs of interest are bone morphogenetic protein-2 (OP-2), bone morphogenetic protein-3 (osteogenin) and bone morphogenetic protein-7 (OP-1). [34] Platelet derived growth factor Platelet-derived growth factor (PDGF) was discovered by Lynch and coworkers in the late 1980s. [35] Moon et al. applied PDGF-BB to promote migration and proliferation of periodontal ligament fibroblasts and demonstrated that PDGF has the capacity to stimulate bone formation and periodontal regeneration in vivo .Thus it holds promise as an important adjuvant to periodontal surgery. [36] Insulin like growth factor Insulin like growth factor (IGF) is a potent chemotactic agent for vascular endothelial cells resulting in increased neovascularization. It also stimulates mitosis of many cells in vitro such as fibroblasts, osteocytes, and chondrocytes. [37] Han and Amar demonstrated that in vitro IGF-I substantially enhanced cell survival in periodontal ligament fibroblast by the upregulation of antiapoptic molecules and downregulation of proapoptotic molecules. [38] Transforming growth factor The two best characterized polypeptides from this group of growth factors are transforming growth factor family (TGF) α and TGF-β.Three forms of TGF-β have been identified namely TGF-β1, TGF-β2, and TGF-β3. TGF-β is chemotactic for fibroblasts and cementoblasts, and promotes fibroblast accumulation and fibrosis in the healing process. It can also modulate other growth factors such as PDGF, TGFα, and EGF and fibroblast growth factor (FGF)possibly by altering their cellular response or by inducing their expression. [39] Oates et al. compared the mitogenic activity of TGF-β with interleukin1 and PDGF in fibroblast cells derived from periodontal ligament explants. TGF-β was relatively a weak mitogen for Periodontal (PDL) cells compared to PDGF, suggesting that TGF-β may indirectly stimulate DNA synthesis. [40] Fibroblast growth factor Fibroblast growth factors are the members of heparin binding growth factor family. The two most thoroughly characterized forms are: Basic FGF (bFGF) and acidic FGF (aFGF).They promote proliferation and attachment of endothelial cells and PDL cells in wound healing process. FGF-2 is known to attract epithelial cells more effectively than FGF-1. [41] Takayama et al. examined the efficiency of topical application of FGF2 with periodontal regeneration in the bony defects by surgically creating furcation class II bone defects in nonhuman primates and concluded that a topical application of FGF-2 can enhance considerable periodontal regeneration. [42] Enamel matrix derivative (EMD) EMD is an acidic extract, containing hydrophobic protein assembly of amelogenins, which has the capacity to induce regeneration of all periodontal tissues. This is obtained from developing porcine teeth and found to contain TGF β and BMP to stimulate bone formation. Enamel matrix derivative stimulates angiogenesis directly by stimulating endothelial cell proliferation and chemotaxis, and stimulates vascular endothelial cell growth factor production by periodontal ligament cells. [43] When applied to root surfaces, the proteins are absorbed into the hydroxyapatite and collagen fibers of the root surface, where they induce cementum formation followedby periodontal regeneration.
Platelet rich plasma
Platelet rich plasma (PRP) is an autologous concentration of platelets, containing a number of important growth factors such as PDGF, TGFβ, IGF, EGF, and VEGF. This mixture of growth factors in platelet rich plasma putatively stimulates the proliferation of fibroblasts and periodontal ligament cells, extracellular matrix formation and neovascularization. Additionally, platelet-rich plasma may suppress cytokine release and limit inflammation, thereby promoting tissue regeneration. [44] PRP also contains proteins (i.e. fibrin, fibronectin, vitronectin) known to act as cell adhesion molecules for osteoconduction and as a matrix for bone, connective tissue, and epithelial migration. [30] Growth factor Tissue engineering approaches for periodontal regeneration Tissue-engineering approaches for periodontal regeneration are nondefinitively subdivided into three principal therapeutic strategies. [31, 45, 46]  cell-based therapy-implantation of freshly isolated or cultured cells, which can be autologous or allogenic cell suspensions or cell-sheets that are injected and/or transplanted to periodontal defect sites. Akizuki et al. investigated periodontal healing after the application of periodontal ligament cell sheet in beagle dogs. These results demonstrated that, in the experimental group, periodontal tissue healing with the formation of bone, periodontal ligament and cementum occurred in three out of the five defects. [47] Hasegawa et al. assessed the ability of periodontal ligament cell sheets to regenerate the periodontal ligament tissue and demonstrated its usefulness in periodontal tissue regeneration. [48] Flores et al. evaluated whether human PDL cell sheet could reconstruct periodontal tissue and found that transplanted PDL cell sheet cultured with osteogenic differentiation medium induced periodontal tissue regeneration containing an obvious cementum layer and Sharpey's fiber. Huang and Zhang have set forward a hypothesis of transplanting PDL cell obtained from the periodontium of autogenous extracted teeth, such as the third molar and premolar for orthodontic purposes sheets when cultured using the cell sheet engineering approach into the implant beds before inserting the implants. [49, 50, 51]  in vitro approaches-implantation of tissues assembled in vitro from cells, scaffolds, and biomolecules (for example, growth factors, growth factor encoding genes, completely lyophilized cell fractions, peptides, and polysaccharides).  in vivo approaches-in situ tissue regeneration by implantation of different types of matrices (such as hydrogels and microspheres/beads) in combination with cells and/or biomolecules, or a scaffold containing biomolecules implanted directly into the defects that stimulates the body's own cells to promote local tissue regeneration.
Applications of tissue engineering in periodontics
Guided Tissue Regeneration (GTR)-The biological principle of using cell occlusive barriers was described by Melcher (1976). [47] Nyman and Karring, in 1982 were the first to have proposed the use of guided tissue regeneration for periodontal regeneration, which marked the evolution of periodontal regeneration technologies using tissue engineering. GTR consists of placing barriers of different types to cover the bone and periodontal ligament (PDL), thus temporarily separating them from the gingival epithelium. This provides space and a favorable niche to guide the right type of cells (PDL cells, cementoblasts, and osteoblasts) to attach at the root surface, and tries to exclude undesirable cells (epithelial cells) from attaching to the root surface.
Guided Bone Regeneration (GBR) -GBR involves the use of membranes to guide the formation of bony tissue by separating the underlying bone from the overlying connective tissue and by creating a space into which the desirable bone cells can migrate. [47] This is usually done before placement of the implant for bone augmentation.
Bone Grafts-Bone grafts aim to restore the height of the alveolar bone around a previously diseased tooth; thus, the principles and techniques from bone regeneration have been directly transferred to periodontal therapy with or without modifications. [52] Currently the gold standard material for bone defect repair is autografts; however, donor site morbidity and limited supply prevent the wide application of this method. Allografts and xenografts are widely available but face issues such as immune rejection and potential transmission of infectious diseases. In view of the limitations inherent with conventional bone graft strategies, tissue engineering represents a promising approach for bone repair and regeneration. Advances in tissue engineering have led to innovative scaffold designs, complemented by progress in the understanding of cellbased therapies and bioactive growth factor delivery.
Recent Advances in Tissue Engineering
Gene therapy  Refers to the treatment of a disease by means of a genetic manipulation.

Genetic information is transferred to the target cells, which enables them to synthesize a protein of interest to treat disease.
Gene transfer is accomplished through the use of viral [retroviruses, adenoviruses (Ad) and adeno-associated viruses (AAV)] and non-viral vectors (plasmids and DNA polymer complexes. [53]  Gene vectors can be introduced directly to the target site (in vivo technique), or selected cell can be harvested, expanded, genetically transduced, and then reimplanted (ex vivo technique). [ 
53]


The application of growth factors or soluble forms of cytokine receptors by gene transfer provides a greater sustainability and bioavailability of growth factors within periodontal wounds. [54] PDGF has demonstrated strong potential in promoting gingival, alveolar bone and cementum regeneration in a variety of wound healing models. When periodontal defects were treated with adenovirus encoding PDGF-B, strong evidence of bone and cementum regeneration beyond that of control vectors, consisting of nearly fourfold increases in bridging bone and six fold increases in tooth-lining cemental repair was seen. [55] Limitations of gene therapy Recombinant Protein Therapeutics With advances in recombinant technology, the development and commercialization of pure recombinant human growth factor matrix combination has been developed. Combination products which represent the next generation of tissue engineering therapeutics, have gained increasing attention from clinicians and researchers as a strategy to optimize tissue regeneration. Proteins may now be synthesized, concentrated, purified, and packaged in large sterile quantities under tightly controlled and regulated conditions. Providing growth modulating molecules in a highly concentrated pure and consistent form and the ability to combine highly concentrated forms of individual signaling proteins with conductive matrices is important in order to increase the predictability of regenerative procedures.
To date, only three recombinant growth factor products have been widely used • rh PDGF BB (gel). [56] • rhPDGFBB (with β tricalcium phosphate). [57] • rh BMP 2 (with type I collagen sponge). [58] The mitogenic responsiveness of periodontal cells to local application of PDGF-BB was confirmed in a dog model by Wang and Castelli. Its levels were raised in cases of periodontitis, but not in diabetic cases; thus, suggesting that PDGFBB driven repair process is suppressed under diabetic conditions. [59] Studies have also suggested that the use of rh PDGF+ β TCP and a collagen membrane may represent an acceptable alternative to connective tissue graft for covering gingival recession defects. [57] The identification and development of recombinant human bone morphogenetic protein -2 (rhBMP2) has led to the commercial availability for the first time of an osteoinductive autograft replacement (INFUSE Bone Graft).
 rhBMP 2 has been combined with ACSatellocollagen sponge (ACS). [60]  rhBMP2 has also been used in a DFDBA/fibrin clot carrier. [61]  rhBMP2 and calcium phosphate cement matrix. [62] Challenges in Tissue Engineering 1. Periodontium being a complex structure, more than one tissue should be reconstructed namely alveolar bone, periodontal ligament, root cementum and gingiva. Hence needs the right combination and dosage of growth factors for successful regeneration.
2. Sustained storage and delivery of growth factors with a suitable carrier system is needed for long term and profound effect and promising regeneration of periodontal tissues. Although many carrier systems have been tested, none of them appears to be ideal.
Conclusion
Tissue engineering has provided us a new therapeutic alternative for the management of periodontal defects. To date, many cellular and molecular mechanisms involved in the repair and regeneration of periodontal tissues have been identified, and advances in the fields of molecular biology, human genetics, and stem cell biology have set the stage for significant discoveries that will pave the way for the development of new tissue-engineering procedures needed for the predictable regeneration of periodontal tissues.
